Healthcare -
Biotechnology - NASDAQ - US
$ 7.47
1.41 %
$ 160 M
Market Cap
-1.59
P/E
ENTA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ENTA - Enanta Pharmaceuticals, Inc.
58.2 M
LAST VALUE
3.00%
2 YEAR CAGR
21.72%
5 YEAR CAGR
61.02%
10 YEAR CAGR